Physician profile
Sidney M Sutton
NPI 1811978158
$1,484.91
in general payments reported to CMS, 2019-2025
13 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $81.25 · 2021: $209 · 2022: $258 · 2023: $239 · 2024: $126 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $525.86 | 2021-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $175.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $166.25 | 2020-2022 | |
| Amgen INC. | $152.99 | 2019-2023 | Otezla |
| Agios Pharmaceuticals, INC. | $99.59 | 2025 | Pyrukynd |
| Teva Pharmaceuticals USA, INC. | $85.00 | 2019 | |
| Merck Sharp & Dohme LLC | $68.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.34 | 2019-2024 | |
| Mylan Specialty L.P. | $50.74 | 2023 | Yupelri |
| Sanofi-Aventis U.S. LLC | $45.74 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $29.94 | 2025 | Neffy |
| Abbott Laboratories | $22.29 | 2024 | Freestyle Libre 3 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.